This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Morgan Stanley: Financial Winner

Stocks in this article: MS

NEW YORK ( TheStreet) -- Morgan Stanley (MS - Get Report) was the winner among the largest U.S. financial names on Wednesday, with shares rising over 4% to close at $18.22.

The broad indexes all saw gains of over 1%, mainly on rumors that China's first-quarter gross domestic product report tonight could show a surprisingly strong annualized growth rate of 9%.

Investors also reacted positively to comments on Wednesday night by Federal Reserve Vice Chair Janet Yellin, describing a "subdued inflation environment," while saying she expected "the economic recovery to continue--indeed, to strengthen somewhat over time," and making a strong case that "a highly accommodative policy stance to be appropriate in present circumstances."

The KBW Bank Index (I:BKX) rose 2% to close at 48.69, with all 24 index components showing gains of at least 1%.

Getting back to Morgan Stanley, the investment bank's shares have now returned 21% year-to-date, following a 44% decline during 2011.

The shares trade for just 0.7 times the company's reported Dec. 30 tangible book value of $27.95, and for eight times the consensus 2013 earnings estimate of $2.31 a share, among analysts polled by Thomson Reuters. The consensus 2012 earnings per share estimate stands at $1.93.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Moody's Investor Service is expected to decide by May 12 whether or not to downgrade its ratings for 17 global financial companies, including Morgan Stanley.

Bank of America Merrill Lynch analyst Guy Moszkowski on Thursday said he was "most cautious" about the effect of the possible downgrades on Morgan Stanley and Citigroup (C), since he expects "derivative counterparties will likely remain highly credit sensitive, and may substantially reduce activity with firms at risk of "Baa"-rating s ."

Calling a three-notch downgrade to a "Baa" rating for Morgan Stanley a "worst case," Moszkowski said a two-notch downgrade was "most likely." He added that the company "could lose substantial share in higher margin/ longer duration derivatives business if the firm is without an A-rated backstop."

Moszkowski has a neutral rating on Morgan Stanley, with a $23 price target, and estimates the company will post first-quarter earnings of 35 cents a share, when it reports its financial results on April 19. The consensus first-quarter EPS estimate is 42 cents.

Interested in more on Morgan Stanley? See TheStreet Ratings' report card for this stock.

RELATED STORIES:




-- Written by Philip van Doorn in Jupiter, Fla.

To contact the writer, click here: Philip van Doorn.

To follow the writer on Twitter, go to http://twitter.com/PhilipvanDoorn.

Philip W. van Doorn is a member of TheStreet's banking and finance team, commenting on industry and regulatory trends. He previously served as the senior analyst for TheStreet.com Ratings, responsible for assigning financial strength ratings to banks and savings and loan institutions. Mr. van Doorn previously served as a loan operations officer at Riverside National Bank in Fort Pierce, Fla., and as a credit analyst at the Federal Home Loan Bank of New York, where he monitored banks in New York, New Jersey and Puerto Rico. Mr. van Doorn has additional experience in the mutual fund and computer software industries. He holds a bachelor of science in business administration from Long Island University.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs